Summary
Updated Aug 31, 2026
Michael David Seckler is Chief Commercial Officer of CorMedix Inc. (CRMD). 1 SEC Form 4 filing on record, dated 16 January 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Michael David Seckler has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael David Seckler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Janet Dillione - $1.55M of CRMD open-market activity in the last 12 months
- Joseph Todisco - $1.01M of CRMD open-market activity in the last 12 months
- Elizabeth Hurlburt - $712K of CRMD open-market activity in the last 12 months
- Kaufman Beth Zelnick - $670K of CRMD open-market activity in the last 12 months
- Steven W. Lefkowitz - $475K of CRMD open-market activity in the last 12 months
- Alan W. Dunton - $391K of CRMD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael David Seckler?
Michael David Seckler is a corporate insider, tracked as Chief Commercial Officer of CorMedix Inc. (CRMD). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Michael David Seckler last file a Form 4?
The only primary Form 4 on record is dated 16 January 2026.
Where can I see all of Michael David Seckler's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael David Seckler and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
